There has been some further FDA action regarding Belviq which is related to the 2020 Belviq drug recall that was due to an increased risk of cancer. This further FDA action means there will be no Belviq generic drugs after the Belviq drug recall in 2020. This February 26, 2021 Notice item, “Determination That BELVIQ (Lorcaserin Hydrochloride) … [Read more...]
FDA Belviq Recall Decision Came After Safety Data Review Found Excess Cancers Risks
In this FDA staff article, “Cancer risk associated with lorcaserin — The FDA’s review of the CAMELLIA-TIMI 61 trial”, which was published by the New England Journal of Medicine (NEJM), the early 2020 FDA Belviq recall decision was explained. Essentially, this FDA action after a careful analysis of Belviq safety data that revealed excess … [Read more...]
Zantac Recall: Chemical NDMA In Zantac Pills Can Cause Cancers
The contaminant chemical NDMA in Zantac pills is a substance that could cause cancer of the: pancreas (pancreatic cancer), stomach, colon, rectum (rectal cancer), bladder, or kidney (renal cancer). On April 1, 2020, the FDA announced that it was requesting a Zantac recall due to the presence of NDMA in Zantac and all other medications containing … [Read more...]
After Drug Recall Belviq Lawsuits Alleging Failure To Warn About Cancer
Following the Belviq recall in February 2020 some of those patients on Belviq developing cancer filed Belviq lawsuits alleging a failure to warn about the risk of cancer associated with Belviq. We are investigating possible Belviq lawsuits that involve patients on Belviq developing cancer. At the present time, our focus for these Belviq lawsuits … [Read more...]
Belviq Recall Due To Certain Cancers: Pancreatic, Colon, Rectal, And Lung
The diet drug Belviq is being withdrawn from the US market because a Belviq safety clinical trial shows an increased occurrence of cancer cases. This February 2020 Belviq FDA Drug Safety Communication announced the Belviq recall, “FDA requests the withdrawal of the weight-loss drug Belviq, Belviq XR (lorcaserin) from the market”, and noted that … [Read more...]
Zantac Cancer Lawsuits Filed After FDA Warnings About NDMA In Ranitidine
Zantac cancer lawsuits are for being filed for patients diagnosed with certain types of cancer after using Zantac (ranitidine) for heartburn associated with acid indigestion and sour stomach. According to medical research, some of the cancers associated with Zantac use due to NDMA exposure include: Stomach cancerColon cancerRectal … [Read more...]